🔵 RESEARCH
Trial builds AI ultrasound system for pediatric neuroblastoma
Researchers registered an observational study to develop an intelligent ultrasound system integrating pathological typing, risk stratification, and prognosis for childhood neuroblastoma.
Specialty pediatric oncology AI signals that ultrasound intelligence is fragmenting into vertical niches. Horizontal POCUS vendors may need deep specialty modules — or licensing deals with academic groups — to defend share in high-value cases.
🔵 RESEARCH
DeepJoint algorithm tracks mammographic density over time for risk
Researchers introduced DeepJoint, an algorithm modelling longitudinal mammographic density evolution and its association with screen-detected breast cancer risk.
If longitudinal density beats static measurement in validation, established mammography AI vendors — iCAD, Hologic, Volpara — face a new competitive vector. Watch for patent filings or licensing within the next 12-18 months.
🔵 RESEARCH
Journal commentary debates multimodal ultrasound AI for diabetic neuropathy
A Journal of Ultrasound in Medicine commentary discusses a machine learning model integrating ultrasound and clinical indicators for diagnosing diabetic peripheral neuropathy.
Multimodal ultrasound AI in diabetic care could erode demand for expensive EMG/NCS testing and open the door for POCUS vendors to embed in diabetes workflows. Diabetes care platforms may seek imaging partners.
Journal of Ultrasound in Medicine · 2026-04-25
Read more → (paywall)
🔵 RESEARCH
Review charts machine learning advances in pelvic adhesion ultrasound
A Journal of Ultrasound in Medicine review examines the progression from traditional sliding sign to machine learning-enhanced ultrasound detection of pelvic adhesions.
Women's health diagnostics remain underserved by AI. First-mover startups productizing this research into FDA-cleared tools could capture share before major ultrasound OEMs integrate similar capabilities — but reimbursement clarity will gate adoption.
Journal of Ultrasound in Medicine · 2026-04-25
Read more → (paywall)
🔵 RESEARCH
Spotlight trial tests bedside POCUS for early post-surgical infection
An observational study is investigating whether point-of-care ultrasound can detect early subcutaneous fluid buildup after laparotomy and predict surgical site infection.
Validation would extend POCUS into post-operative monitoring — a new addressable market for handheld vendors like Butterfly and GE HealthCare. Adoption depends on hospitals solving the bedside sonographer staffing question.
🔵 RESEARCH
Imaging detects prostate cancer progression when PSA stays stable
A pooled analysis of two trials in JCO found imaging detects metastatic prostate cancer progression in patients on androgen receptor inhibitors even when PSA remains flat.
The finding strengthens the case for PSMA-PET and multiparametric MRI over PSA-only surveillance. Expect guideline pressure and prior-authorization friction as urologists justify imaging when biomarkers don't flag medical necessity.
🩺 EDITOR’S TAKE — FOR CLINICIANS
Imaging is increasingly outpacing biomarkers as the earliest signal of disease change — the prostate cancer findings make that explicit. Reassess surveillance protocols where PSA, density, or sliding-sign assessments still drive decisions in isolation.
📊 EDITOR’S TAKE — FOR INVESTORS
Today's pipeline is academic, but the pattern is clear: ultrasound AI is fragmenting into specialty verticals — pediatric oncology, pelvic adhesions, neuropathy, post-op infection. Horizontal POCUS platforms without deep specialty modules face mounting competitive risk.
🏭 EDITOR’S TAKE — FOR INDUSTRY
OEMs should be scanning these research groups for licensing targets before purpose-built startups productize them first. Workflow integration — sonographer staffing, protocol standardization, reimbursement — remains the gating factor on every clinical study landing today.